Sort by
Refine Your Search
-
span to fight variety of diseases across the organism. A first in human clinical trial of DOS will be held in the UK in 2025; as such candidates will be exposed to an extraordinary work flow spanning
-
for Craniofacial Molecular Biology (CCMB), University of Southern California (USC), Los Angeles. The Chen lab investigates neuroscience and craniofacial biology, crosstalk, and disease. The lab uses mouse and human
-
of the art human tissue and organoid systems to evaluate the impacts of known and novel carcinogenic and microbial metabolites. The ideal candidate should have a strong background in immunology (especially
-
caregivers and can result in substantial cost savings to healthcare systems. The goal of the present research project is to validate novel biomarkers of cholinergic dysfunction in human biofluids from
-
. Our goal is to tackle fundamental problems in human health with cutting-edge technologies and through interdisciplinary collaborations with world-class scientists and physicians in Beijing. CIMR will
-
variety of basic biology questions revolving around the regulation and dysregulation of the human genome. We use these approaches to address multiple diseases, including leukemia, aging, and
-
Institute of Technology (KIT), Human Resources, Hermann-von-Helmholtz-Platz 1, 76344 Eggenstein-Leopoldshafen, Germany. For further information, please contact Dr. Emilia Grass, email: [email protected]
-
breakthroughs in basic research to advances in human health. The Max Perutz Labs are located at the Vienna BioCenter, one of Europe’s hotspots for Life Sciences, and host 44 research groups, involving around 400
-
processes, scientists at the Max Perutz Labs aim to link breakthroughs in basic research to advances in human health. The Max Perutz Labs are located at the Vienna BioCenter, one of Europe’s hotspots for Life
-
relationship to both neurodegenerative disease and cancer. Application deadline is 18 June 2024. Description of the project A postdoctoral fellowship is available in the laboratory of Dr. Jonathan Gilthorpe